RxAll Inc.
RxAll Inc. is an health information technology/big data startup company. The company works with drug regulatory agencies and other stakeholders[1]to reduce fake medicines and make sure that patients receive high quality verified drugs, and help pharma manufacturers gain more sales, and patients have better access to high quality drugs.
Private | |
Industry | Medical Technology |
Founded | January 1, 2016. |
Headquarters | 165 Whitney Avenue, New Haven, Connecticut 06520, United States. |
Area served | Worldwide |
Key people | Adebayo Alonge (founder / CEO) Amy Kao (Co-founder / CMO) Wei Liu (Co-founder / CTO) |
Products | Medical Devices |
Total equity | 3.3 Million US dollar. |
Website | www.rxall.net/about-us rxalldelivered.com |
Founding History
RxAll Inc. was established on January 1, 2016 by Adebayo Alonge, Amy Kao and Wei Liu. They were graduate students of Yale University - Yale School of Management at the time.[2] It is seen as an important weapon against illegal pharmaceutical outfits in Kenya. [3] Alonge was nearly killed by fake salbutamol tablets in Nigeria in 2005. [4]
Early Challenges
Like many start-ups, RxAll Inc. came up against early challenges[5] when it almost ran out of cash in the first quarter of 2017, the founding team persisted to raise funds in parallel to operating the business. [6]Co-founders Adebayo Alonge and Amy Kao managed to raise about $1 million in grants and bootstrapped funds from the Nigerian government, the Yale start-up ecosystem, Merck, Villgro and other support networks.[7]
Products
The company's products are:
RxScanner
RxScanner is an handheld drug authenticator device created for patients to verify their drugs and help drug regulators to reduce administrative burden, improve record keeping and also improved productivity and successful prosecution of bad actors.[8] The devise is in use by country FDAs, Hospitals, Pharmacies and Big Pharma across the world.[9]
RxAll POS
RxAll POS is a Point of sale software created for Pharmacies in growth market that[10]enables complete automation of the pharmacy management system.
Growth and Expansion
In the space of two years, RxAll Inc. achieved a multi-million dollar valuation and ramped up seven-figure sales orders in its first year.[13] Through the effort of its CEO, the company gained market entry into East Africa (Kenya and Uganda), West Africa (Nigeria and Ghana), Southeast Asia (Myanmar, Malaysia and Singapore), and the Americas (Canada, United States and Colombia).[14]
Investors
Some of the company's investors are:
- HAX (HAX Accelerator)
- SOSV ( The accelerator VC)
- Brinc
- Hello Tomorrow
- Innovate Yale.[15]
- Merck.
- Plug and Play Tech Center.
- Equilateral Ventures.
- Angel Challenge See.
- Takuma Terakubo.
Award
RxAll Inc. won the 2019 BNP Paribas group deep tech award otherwise known as Hello Tomorrow, a competition crafted for tech innovators and entrepreneurs, worth €100,000.[16]
Also, the company was the recipient of 2018 CIO Review Most Promising PharmaTech Vendor Award and 2018 Katapult FutureFest's Glstart-up award in Oslo, Norway.[17][18]
External Links
References
- "RxAll Inc. Making giant stride". How we made it in Africa. 2017-10-19.
- RxAll (2018-07-23). "RxAll Inc. signs MOU with CTI Africa". Medium. Retrieved 2020-01-26.
- "How Advances in Tech Are Battling the Fake Meds Epidemic (In Kenya)". Nairobi Wire. 24 January 2020. Retrieved 8 February 2020.
- "Fighting fake medicines". Chemistry World. 16 May 2019. Retrieved 8 February 2020.
- "Startup Saves Lives by Ridding African Market of Counterfeit Drugs". Yale School of Management. 2018-04-06. Retrieved 2020-06-21.
- am, Amy Xiong 12:21; Apr 06; 2018. "New startup targets fake drugs". yaledailynews.com. Retrieved 2020-06-21.CS1 maint: numeric names: authors list (link)
- "Providing Safe Medication for a Better Tomorrow: RxAll". The Silicon Review. Retrieved 2020-06-21.
- "RxAll, Founded by Adebayo Alonge '16, Named Best Early-Stage Startup in Hello Tomorrow Global Challenge". Yale School of Management. 2019-03-21. Retrieved 2020-01-26.
- "RxAll Inc". F6S. Retrieved 2020-01-26.
- Leadership, Insurance Thought. "RxAll Inc". Innovator's Edge. Retrieved 2020-01-26.
- "Opinion: How social enterprises are playing a role in COVID-19 response". Devex. 2020-05-06. Retrieved 2020-06-21.
- "Opinion: How social enterprises are playing a role in COVID-19 response". Devex. 2020-05-06. Retrieved 2020-08-07.
- "RxAll Inc. moving ahead". CrunchBase.
- "Fight the fakes: how to beat the $200bn medicine counterfeiters". Guardian. 5 June 2019. Retrieved 11 February 2020.
- "RxAll Inc. making terrific progress". Angel.
- "For His Anti-Fake Drugs Startup, Nigerian Pharmacist Bayo Alonge Beats 4,500 From 119 Countries To Win €100,000 Prize". Sahara Reporters. 21 March 2019. Retrieved 11 February 2020.
- thetechtribune (2020-03-19). "Amy Kao of RxAll". The Tech Tribune. Retrieved 2020-08-07.
- "RxAll: The Unsung Heroes Combating Counterfeit Medicine". pharma-life-sciences.cioreview.com. Retrieved 2020-08-07.